Furthermore, we have established that SorLA extracellular domain interacts directly with HER2 and HER3 and that this interaction is necessary for SorLA‐dependent proliferation of HER2‐positive breast cancer cell lines [19]. Here, ERBB3 is linked to breast carcinoma.